Not Yet RecruitingNot Applicable

Effect of Botulinum Toxin a Injection in Treatment of Recession RT1 and RT2

28 participantsStarted 2025-04-04

Plain-language summary

The goal of this study type: clinical trial\] is to learn the effect of Botulinum Toxin \_A injection in treatment of RT1andRT2 Gingival recession in lower anterior teeth . Primary outcome is keratinzed tissue width. Researchers will compare Coronally Advanced flap with De-epithelized free gingival graft and Botulinum toxin-A injection in Mentalis muscle with coronally advanced flap with De-epithelized free gingival graft alone . The outcome will be measured at baseline, after 3 months and after 6 mobths \_medical history * 3 mm horizontal incisions, then two vertical incisions * deepitheliztion of anatomical papillae * superficial and deep incisions * harvesting DFGG * Suturing * BOTOX injection

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Single or multiple RT1, RT2 GR patient * patients ≥18 years * systemically healthy, full mouth plaque score, full mouth bleeding score ≤ 15% after phase I therapy * clinical indication and/or patient request for recession coverage * well motivated patients, maintaining oral hygiene throughout study Exclusion Criteria: * Pregnant or lactating women * Smokers' patients * Teeth with cervical restorations/abrasion. * Patients had a systemic condition affect blood components and healing

What they're measuring

Keratinized tissue width

Timeframe: Measured at baseline ,3months ,6 months

Trial details

NCT IDNCT06842290

SponsorCairo University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-10-16

View on ClinicalTrials.gov More Gingival Recession trials